Tweenvest Stocks

Mono Pharmacare Limited (NSEI: MONOPHARMA)

Health Care · Health Care Providers & Services · IN

Rs8.90

+4.09% today · -58.4% 1Y

Mono Pharmacare Limited (NSEI: MONOPHARMA) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $1.62M and employs 115 people.

Over the last twelve months the share price has lost 58.4%, trading between 7.50 and 22.05.

Tweenvest scores Mono Pharmacare Limited across four factors: quality 46/100, value 71/100, growth 100/100. Its strongest factor is growth.

MONOPHARMA price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$1.62M
Revenue (TTM)
$17.67M
P/E
21.71
EPS
0.41
Dividend yield
—
Beta (5Y)
-0.29
52-week high
Rs22.05
52-week low
Rs7.50
Avg volume (3M)
—
Shares outstanding
17.67M
Employees
115
Next earnings
—

About Mono Pharmacare Limited

Established in 1964, Mono Pharmacare Limited, headquartered in Ahmedabad, India, specializes in the marketing and distribution of a wide array of pharmaceutical and healthcare products. Its diverse product offerings span numerous categories, such as antibiotics, antifungals, cold and allergy remedies, digestive aids, pain relievers, nutritional supplements, skincare, antiseptics, and specialized solutions for cardiac, diabetic, and cosmetic needs.

ISIN
INE0OIP01012
Founded
1964
Listed since
Sep 7, 2023
Exchange
National Stock Exchange of India
Currency
INR
CompanyMarket capPriceDay
Nexus Surgical and Medicare LimitedBSE: 538874$1.77MRs31.38-0.35%
Centuple Global LimitedBSE: 531099$1.72MRs30.48-4.39%
Saroja Pharma Industries India LimitedNSEI: SAROJA$1.71MRs40.80+4.88%
Hedera Group AB (publ)OM: HEGR$1.64MSkr0.48+5.26%
Acro Biomedical Co., Ltd.OTCPK: ACBM$1.56M$——
Virax Biolabs Group LimitedNasdaqCM: VRAX$1.49M$1.870.00%
Medical Marijuana, Inc.OTCPK: MJNA$1.39M$0.00-50.00%
Global Longlife Hospital and Research LimitedBSE: 543520$1.36MRs12.52+3.05%

Browse every Health Care Providers & Services company →

Figures last refreshed Oct 11, 2026.